GET THE APP

Chemotherapy: Open Access

Chemotherapy: Open Access
Open Access

ISSN: 2167-7700

Chemotherapy: Open Access : Citations & Metrics Report

Articles published in Chemotherapy: Open Access have been cited by esteemed scholars and scientists all around the world. Chemotherapy: Open Access has got h-index 11, which means every article in Chemotherapy: Open Access has got 11 average citations.

Following are the list of articles that have cited the articles published in Chemotherapy: Open Access.

  2020 2019 2018 2017 2016

Year wise published articles

8 0 17 24 52

Year wise citations received

69 94 79 145 115
Journal total citations count 615
Journal impact factor 4.06
Journal 5 years impact factor 4.96
Journal cite score 7.88
Journal h-index 11
Journal h-index since 2017 10
Important citations

satya srinivas v. research and reviews: journal of medical and health sciences.

anitha sri s, prudhvi raj p. incidence and prevalence of breast cancer in usa. biochem mol biol lett. 2017;2(1):102.

alshehri af, alnatsheh a, aseeri m, al fayea t. evaluation of the use of granulocyte colony-stimulating factors (g-csfs) for neutropenia primary prophylaxis in solid tumors at a tertiary care hospital, retrospective study. j pharmacovigil. 2017;5(248):2.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

rachana n. research & reviews: journal of pharmaceutics and nanotechnology.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

rachana n. research & reviews: journal of pharmaceutics and nanotechnology.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

bala r, sharma d, kaur a. research & reviews: journal of medical and health sciences.

kamini j. why imatinib is by far the best drug to treat chronic myeloid leukemia. biochem mol biol lett. 2017;3(2):112.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

tripathi s, madan a. biomarkers role in breast cancer treatment-a review.

joyal v. research and reviews: journal of pharmacy and pharmaceutical sciences neoplastic diseases: a mini-review.

Relevant Topics

Top